Olaison G, Sjödahl R, Tagesson C
Department of Surgery, University Hospital, Linköping, Sweden.
Digestion. 1988;41(3):136-41. doi: 10.1159/000199765.
The activity of phospholipase A2 (EC 3.1.1.4) in endoscopic biopsy specimens of intestinal mucosa was compared in patients with Crohn's disease and controls without inflammatory bowel disease. In postresection Crohn patients there was significantly enhanced phospholipase A2 activity proximal to the anastomosis in the neoterminal ileum, whether or not the mucosa was inflamed at the time of biopsy. Highly elevated ileal phospholipase A2 activity had a predictive value for symptomatic relapse within 1 year after resection. Patients with concomitant Crohn's colitis, in whom the risk of ileal recurrence is particularly high, had greater ileal phospholipase A2 activity than noncolitis Crohn patients. Association thus was demonstrated between activity of phospholipase A2 in ileal mucosa and proneness to ileal inflammation in Crohn's disease.
比较了克罗恩病患者和无炎症性肠病的对照者肠道黏膜内镜活检标本中磷脂酶A2(EC 3.1.1.4)的活性。在切除术后的克罗恩病患者中,无论活检时黏膜是否发炎,在新末端回肠吻合口近端的磷脂酶A2活性均显著增强。回肠磷脂酶A2活性高度升高对切除术后1年内的症状复发具有预测价值。伴有克罗恩病结肠炎的患者,其回肠复发风险特别高,其回肠磷脂酶A2活性高于无结肠炎的克罗恩病患者。因此,证实了回肠黏膜中磷脂酶A2的活性与克罗恩病回肠炎症倾向之间存在关联。